Breast Cancer Tumor Care Observational Programme

Verified by: AstraZeneca, December 2009
First Received: April 15, 2008 | Last Updated: December 8, 2009 | Phase: N/A | Start Date: February 2008
Overall Status: Active, not recruiting | Estimated Enrollment: 150
  • …
  • Tell a FriendPrint

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment...

Brief Summary

Official Title: “Breast Cancer Tumor Care Patient Observation Programme”

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

  • Study Type: Observational
  • Study Design: Observational Model: Case-Only, Time Perspective: Prospective

Intervention(s) in this Clinical Trial

  • Drug: anastrozole
    • Oral

Arms, Groups and Cohorts in this Clinical Trial

  • : 1

Outcome Measures for this Clinical Trial

Primary Measures

  • Progression of disease and tolerability in general
    • Time Frame: Baseline, every 3 month
      Safety Issue?: No

Secondary Measures

  • Patient questionnaire to collect data on Incidence, time of onset and treatment of arthralgia
    • Time Frame: Baseline, every 3 month
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Postmenopausal women
  • Already on upfront Arimidex Therapy (Start 1-4 weeks before)
  • HR+

Exclusion Criteria:

  • Premenopausal women
  • Tamoxifen switch patients

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: AstraZeneca Industry

Overall Clinical Trial Officials and Contacts

Dr. Melichart Study Chair Hospital Rudolfstiftung  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00660244

Study ID Number: NIS-OAT-ARI-2007/1

ClinicalTrials.gov Identifier: NCT00660244

Health Authority: Austria: Agency for Health and Food Safety

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00660244